文献速递流行病学与生物统计组学、生物样本库与精准医学

抗生素对中低收入国家儿童生命早期肠道微生物组组成和耐药组的影响:一项系统综述

Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review.
PubMed 文献 · PLoS Med · 2023-06-27

该系统综述检索多个数据库,纳入10项在中低收入国家开展的针对2岁以下儿童的随机对照试验,评估抗生素使用后肠道微生物组组成和/或耐药组组成的变化。结果显示,与安慰剂相比,抗生素降低肠道微生物组多样性并增加抗生素特异性耐药基因丰度;最常测试的阿奇霉素在治疗后5天即降低微生物组多样性并显著增加大环内酯类耐药。

要点

  • 在中低收入国家2岁以下儿童中,与安慰剂相比,抗生素降低肠道微生物组多样性并增加抗生素特异性耐药基因丰度。
  • 最常测试的阿奇霉素在治疗后5天即降低肠道微生物组多样性并显著增加大环内酯类耐药。
  • 现有研究在方法学、采样时间和时长及测序方法上存在相当大的异质性,限制了对抗生素影响的深入理解。

核心结论

  • 在中低收入国家,抗生素显著降低婴儿肠道微生物组多样性并改变其组成,同时选择出耐药基因,这些基因的持久性可在治疗后持续数月。
  • 现有研究在方法学、采样时间和时长及测序方法上的相当大的异质性限制了对中低收入国家儿童抗生素对微生物组和耐药组影响的深入理解。
  • 迫切需要更多研究来填补这一空白,以更好地理解抗生素驱动的微生物组多样性降低和抗菌药物耐药基因选择是否使中低收入国家儿童面临不良健康结局的风险,包括感染携带抗菌药物耐药病原体。

研究设计与样本

  • 系统综述,检索MEDLINE(1946年至2023年1月28日)、EMBASE(1947年至2023年1月28日)、SCOPUS(1945年至2023年1月29日)、WHO Global Index Medicus(检索至2023年1月29日)和SciELO(检索至2023年1月29日)。
  • 共检索到4369篇文章,去除重复后得到2748篇独特文章,经标题和摘要筛选排除2666篇,对92篇文章进行全文评估,最终10项研究符合纳入标准。
  • 纳入标准为在中低收入国家开展的针对2岁以下儿童的人体研究,报告抗生素使用后肠道微生物组组成和/或耐药组组成(抗菌药物耐药基因)。
  • 纳入的研究均为随机对照试验(RCT),并使用Cochrane随机研究偏倚风险评估工具进行偏倚风险评估。

主要发现

  • 总体而言,与安慰剂相比,抗生素治疗组肠道微生物组多样性降低,抗生素特异性耐药基因丰度增加。
  • 最常测试的抗生素是阿奇霉素,其在治疗后5天即降低肠道微生物组多样性并显著增加大环内酯类耐药。

局限性

  • 本研究的一个主要局限性是覆盖该主题领域的可用研究很少。
  • 具体而言,评估的抗生素范围未包括中低收入国家人群中最常用的抗生素。
  • 现有研究在方法学、采样时间和时长及测序方法上存在相当大的异质性,限制了对中低收入国家儿童抗生素对微生物组和耐药组影响的深入理解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately burdened by AMR and young children are especially vulnerable to infections with AMR-bearing pathogens. The impact of antibiotics on the microbiome, selection, persistence, and horizontal spread of AMR genes is insufficiently characterized and understood in children in LMICs. This systematic review aims to collate and evaluate the available literature describing the impact of antibiotics on the infant gut microbiome and resistome in LMICs. METHODS AND FINDINGS: In this systematic review, we searched the online databases MEDLINE (1946 to 28 January 2023), EMBASE (1947 to 28 January 2023), SCOPUS (1945 to 29 January 2023), WHO Global Index Medicus (searched up to 29 January 2023), and SciELO (searched up to 29 January 2023). A total of 4,369 articles were retrieved across the databases. Duplicates were removed resulting in 2,748 unique articles. Screening by title and abstract excluded 2,666 articles, 92 articles were assessed based on the full text, and 10 studies met the eligibility criteria that included human studies conducted in LMICs among children below the age of 2 that reported gut microbiome composition and/or resistome composition (AMR genes) following antibiotic usage. The included studies were all randomized control trials (RCTs) and were assessed for risk of bias using the Cochrane risk-of-bias for randomized studies tool. Overall, antibiotics reduced gut microbiome diversity and increased antibiotic-specific resistance gene abundance in antibiotic treatment groups as compared to the placebo. The most widely tested antibiotic was azithromycin that decreased the diversity of the gut microbiome and significantly increased macrolide resistance as early as 5 days posttreatment. A major limitation of this study was paucity of available studies that cover this subject area. Specifically, the range of antibiotics assessed did not include the most commonly used antibiotics in LMIC populations. CONCLUSION: In this study, we observed that antibiotics significantly reduce the diversity and alter the composition of the infant gut microbiome in LMICs, while concomitantly selecting for resistance genes whose persistence can last for months following treatment. Considerable heterogeneity in study methodology, timing and duration of sampling, and sequencing methodology in currently available research limit insights into antibiotic impacts on the microbiome and resistome in children in LMICs. More research is urgently needed to fill this gap in order to better understand whether antibiotic-driven reductions in microbiome diversity and selection of AMR genes place LMIC children at risk for adverse health outcomes, including infections with AMR-bearing pathogens.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Luchen CC, Chibuye M, Spijker R, et al. Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review. PLoS Med. 2023. PMID: 37368871. doi:10.1371/journal.pmed.1004235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。